# Invesco Pharmaceuticals ETF (PJP)

> Source: Nexqual · https://nexqual.com/PJP · data as of 2026-10-23 19:59 UTC · cite as "Nexqual, Invesco Pharmaceuticals ETF (PJP), nexqual.com/PJP" · informational, not investment advice.

**Price:** USD 125.03 (-1.79% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 125.03 · day 125–126.19 · 52w 94.89–131.68 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +32.9% vs S&P 500 +13.4%; 5Y +66.3% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +32.9% | +66.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +33.0% | +10.7% |
| Volatility (annualized) | 17.5% | 16.1% |
| Max drawdown | -9.4% (Feb 2026→Mar 2026) | -17.5% (Apr 2022→Oct 2023) |

## Peers
PBE (Invesco Biotechnology & Genome ) USD 98.72 -0.67% · IHE (iShares U.S. Pharmaceutical ETF) USD 102.51 -2.17% · XPH (State Street SPDR S&P Pharmaceu) USD 62.7 -2.46% · PBJ (Invesco Food & Beverage ETF) USD 47.93 -1.03% · FBT (First Trust Amex Biotech Index ) USD 269.25 -1.26%

## More
Full page: https://nexqual.com/PJP · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt